How to Help Your Patients Find Apriso in Stock: A Provider's Guide

When a patient calls your office saying they can't fill their Apriso prescription, the conversation usually ends one of two ways: with a frustrated patient and an overworked staff member spending 30 minutes on the phone with pharmacies, or with a treatment interruption that shouldn't happen. Neither is acceptable.

This guide provides a systematic approach to helping your ulcerative colitis patients access Apriso (Mesalamine ER) efficiently, without consuming excessive clinical staff time. We'll cover the current availability landscape, why patients are struggling, and five concrete steps your practice can implement today.

Current Availability Picture

Apriso (Mesalamine 0.375 g extended-release capsules) and its generic equivalents are not in formal shortage as of 2026. National supply from Salix Pharmaceuticals and multiple generic manufacturers is adequate. However, individual pharmacy availability varies significantly due to:

• Generic-first stocking: Most retail chains stock generic Mesalamine ER exclusively. Brand-name Apriso may need to be special-ordered.
• Demand-based inventory: Automated ordering systems at chain pharmacies deprioritize lower-volume specialty medications. A pharmacy dispensing only a few Mesalamine ER prescriptions per month may not maintain consistent stock.
• Regional variation: Wholesale distribution patterns create geographic pockets of limited availability.
• Insurance friction: Prior authorization and step therapy requirements delay dispensing, which patients often misinterpret as a supply problem.

For the detailed supply timeline, see our companion piece: Apriso shortage: what providers and prescribers need to know in 2026.

Why Patients Can't Find It

Understanding the patient's perspective helps frame effective solutions:

The Brand vs. Generic Disconnect

Patients prescribed "Apriso" may not realize that generic Mesalamine ER is the same medication. When their pharmacy doesn't carry brand-name Apriso, they report being unable to find their medication — even though the generic equivalent is on the shelf. Clear communication about generic equivalence can resolve many of these situations immediately.

Pharmacy Loyalty

Many patients use a single pharmacy for all their prescriptions and don't consider alternatives when that location is out of stock. Empowering patients to check other pharmacies — or proactively routing prescriptions to stocked locations — can eliminate most access issues.

Cost Confusion

Some patients can't fill their prescription because they can't afford it, not because it's unavailable. Brand-name Apriso costs $500–$700/month without insurance. Generic Mesalamine ER can be as low as $42–$55/month with a coupon card. Ensuring patients know about these options prevents unnecessary treatment interruptions.

5 Steps Providers Can Take

Step 1: Prescribe Generically

The single most impactful thing you can do is prescribe generic Mesalamine ER (0.375 g) rather than brand-name Apriso. This:

• Allows pharmacies to fill from any manufacturer in stock
• Reduces prior authorization requirements on most plans
• Dramatically lowers patient out-of-pocket costs
• Increases the number of pharmacies that can fill the prescription

If writing for the brand is necessary, ensure "substitution permitted" is not restricted on the prescription.

Step 2: Use Medfinder to Route Prescriptions

Medfinder for providers offers real-time pharmacy stock data. Before sending a prescription, your staff can verify the receiving pharmacy has Mesalamine ER in stock. This eliminates the common scenario where an e-script arrives at a pharmacy that doesn't carry the medication, triggering a callback to your office.

Implementation tips:

• Bookmark medfinder.com/providers in your EHR workstations
• Train MAs and refill coordinators to check availability before routing prescriptions
• Share medfinder.com with patients so they can self-serve for refills

Step 3: Prepare Patients for the Generic Conversation

Proactively tell patients:

• "I'm prescribing Mesalamine ER — this is the same medication as Apriso, just the generic version"
• "The pharmacy may give you a bottle labeled Mesalamine ER instead of Apriso — that's correct"
• "If cost is ever a concern, a coupon card can bring the generic price down to about $42 to $55 per month"

This small investment in counseling prevents confusion and phone calls later.

Step 4: Have Backup Alternatives Ready

When Mesalamine ER is genuinely unavailable, be prepared to pivot quickly. Keep these alternatives in mind:

• Lialda (Mesalamine 1.2 g DR tablets): Once-daily, approved for induction and maintenance. Dose: 2.4–4.8 g/day for induction, 2.4 g/day for maintenance.
• Pentasa (Mesalamine 250/500 mg CR capsules): Four-times daily, releases throughout GI tract. Total dose: 4 g/day.
• Delzicol (Mesalamine 400 mg DR capsules): Three-times daily, targets terminal ileum/colon. Dose: 2.4 g/day induction, 1.6 g/day maintenance.

When switching formulations, document the reason and schedule a follow-up within 4–6 weeks to assess response.

Patient-facing resource: Alternatives to Apriso.

Step 5: Connect Patients to Cost Resources

Medication adherence often breaks down at the pharmacy counter when patients face unexpected costs. Equip your practice with these resources:

• Salix Savings Card: $0 first fill, $10 subsequent fills (max $100 benefit) for commercially insured patients
• Coupon cards: SingleCare, GoodRx — generic Mesalamine ER as low as $42/month
• Patient Assistance Programs: Bausch Health PAP for uninsured/underinsured patients
• Third-party services: Prescription Hope (~$50/month service fee for brand access)

Consider printing a one-page handout with these resources for your front desk to distribute. Detailed information: How to help patients save money on Apriso: provider's guide.

Workflow Tips for Your Practice

Integrating these steps into your existing workflow doesn't have to be complicated:

For New UC Patients

1. Discuss generic Mesalamine ER during the initial visit
2. Confirm preferred pharmacy and check Medfinder for stock
3. Provide cost resource handout
4. Document generic substitution preference in the chart

For Existing Patients Reporting Access Issues

1. Verify whether the issue is supply-related or cost-related
2. If supply: check Medfinder, redirect prescription to a stocked pharmacy
3. If cost: connect to coupon cards or PAP
4. If persistent: consider switching to alternative Mesalamine formulation

For Refill Coordination Staff

• When processing refill requests, default to generic Mesalamine ER unless chart indicates brand-only
• If pharmacy reports stock-out, check Medfinder and redirect rather than waiting for restock
• Keep a list of 2–3 reliable pharmacies (including at least one independent) that consistently stock Mesalamine ER

Drug Interaction Reminders

When managing UC patients on Mesalamine, keep these interactions on your radar:

• Thiopurines (Azathioprine, 6-MP): Mesalamine inhibits TPMT, potentially increasing thiopurine metabolite levels. Monitor CBC and consider dose adjustment.
• NSAIDs: Additive nephrotoxicity risk with chronic use. Monitor renal function.
• Antacids: Specifically contraindicated with Apriso/Mesalamine ER due to pH-dependent release mechanism. Counsel patients to separate or avoid.

Full interaction guide: Apriso drug interactions: what to avoid.

Final Thoughts

Medication access issues for Apriso are solvable with a proactive, systematic approach. The combination of generic prescribing, real-time availability tools like Medfinder, prepared backup plans, and patient cost education can virtually eliminate treatment interruptions for your UC population.

The time investment is minimal — most of these steps can be delegated to clinical support staff — and the return is significant: better adherence, fewer flares, and fewer after-hours calls from frustrated patients.

Share with your patients: How to find Apriso in stock near you.